Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report.

Autor:	Kaiho-Sakuma M; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Toyoshima M; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Watanabe M; Department of Pathology, Tohoku University Hospital, Sendai, Japan., Toki A; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Kameda S; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Minato T; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Niikura H; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan.
Jazyk:	angličtina
Zdroj:	Gynecologic oncology reports [Gynecol Oncol Rep] 2018 Jan 04; Vol. 23, pp. 20-23. Date of Electronic Publication: 2018 Jan 04 (Print Publication: 2018).
DOI:	10.1016/j.gore.2018.01.002
Abstrakt:	•Neuroendocrine tumors (NETs) frequently occur in the lungs or the gastrointestinal tract; they are uncommon in the ovary.•The mammalian target of rapamycin (mTOR) pathway has been reported as a treatment for advanced NETs.•We describe a patient with an aggressive primary ovarian NET, successfully treated with everolimus (an mTOR inhibitor).
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu